Ausgabe 1/2014
Inhalt (9 Artikel)
Activation of local and systemic anti-tumor immune responses by ablation of solid tumors with intratumoral electrochemical or alpha radiation treatments
Yona Keisari, Ilan Hochman, Hila Confino, Rafi Korenstein, Itzhak Kelson
Chronic inflammation and cancer: suppressing the suppressors
Michal Baniyash, Moshe Sade-Feldman, Julia Kanterman
Advantages and clinical applications of natural killer cells in cancer immunotherapy
Erik Ames, William J. Murphy
Antitumor immune responses induced by ionizing irradiation and further immune stimulation
Benjamin Frey, Yvonne Rubner, Lorenz Kulzer, Nina Werthmöller, Eva-Maria Weiss, Rainer Fietkau, Udo S. Gaipl
Non-genomic events determining the sensitivity of hemopoietic malignancies to glucocorticoid-induced apoptosis
Shlomit Kfir-Erenfeld, Eitan Yefenof
Clinical evaluation of systemic and local immune responses in cancer: time for integration
Dmitriy W. Gutkin, Michael R. Shurin
Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy
Alexandr V. Bazhin, Ivan Shevchenko, Viktor Umansky, Jens Werner, Svetlana Karakhanova
Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?
Theresa L. Whiteside
Cellular and molecular pathways in the tumor immunoenvironment: 3rd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, 22–25 April 2013, Krakow, Poland
Michael R. Shurin, Viktor Umansky, Anatoli Malyguine, Arthur A. Hurwitz, Ron N. Apte, Theresa Whiteside, Anahid Jewett, Yasmin Thanavala, William J. Murphy